GAMMAGLOBULINA ANTIHEPATITIS-B P BEHRING GER Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

gammaglobulina antihepatitis-b p behring ger

ΙΦΕΤ ΑΕ - ΑΝΘΡΩΠΙΝΗ ΑΝΘΡΩΠΙΝΗ ΑΙΣΘΗΤΙΚΗ - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 1000 iu/5ml - 8000043972 - hepatitis b immunoglobulin human - 0.000000

SINERGINA 100MG TABLETS Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

sinergina 100mg tablets

faes farma sa (0000002088) maximo aquirre 14, leioa(vizcaya), 48940 - phenytoin - tablets - 100mg - phenytoin (0000057410) 100mg - phenytoin

VIGAM LIQUID 5G/100ML SOLUTION FOR INTRAVENOUS INFUSION Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

vigam liquid 5g/100ml solution for intravenous infusion

bio products laboratory limited (0000009242) dagger lane, elstree, hertfordshire, wd6 3bx - immunoglobulin human normal - solution for intravenous infusion - 5g/100ml - immunoglobulin human normal (8000012671) 5% w/v - immunoglobulins, normal human, for intravasc. adm.

Flebogamma DIF (previously Flebogammadif) Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - Ανθρώπινη φυσιολογική ανοσοσφαιρίνη - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - Άνοσοι οροί και ανοσοσφαιρίνες, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Imbruvica Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

imbruvica

janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.

Brukinsa Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Αντινεοπλασματικοί παράγοντες - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

THYMOGLOBULINE PD.SOL.INF 25MG/VIAL Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

thymoglobuline pd.sol.inf 25mg/vial

genzyme europe b.v., holland paasheuvelweg 25, 1105 bp amsterdam - human anti-thymocyte rabbit immunoglobulin - pd.sol.inf (ΚΟΝΙΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 25mg/vial - human anti-thymocyte rabbit immunoglobulin 25mg - antithymocyte immunoglobulin (rabbit)

SANDOGLOBULIN LY.PD.INJ 6 G Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

sandoglobulin ly.pd.inj 6 g

zlb behring ΜΕΠΕ Μιχαλακοπούλου 35,, 115 28 ΑΘΗΝΑ 210-7255660 - immunoglobulin human normal - ly.pd.inj (ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ) - 6 g - immunoglobulin human normal

SANDOGLOBULIN LY.PD.INJ 3 G Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

sandoglobulin ly.pd.inj 3 g

zlb behring ΜΕΠΕ Μιχαλακοπούλου 35,, 115 28 ΑΘΗΝΑ 210-7255660 - immunoglobulin human normal - ly.pd.inj (ΕΝΕΣΙΜΟ ΛΥΟΦΙΛΟ) - 3 g - immunoglobulin human normal

THYMOGLOBULIN/PAST.MERIEUX PS.SOL.INF 25MG Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

thymoglobulin/past.merieux ps.sol.inf 25mg

ΙΦΕΤ ΑΕ 18ο χλμ. Λεωφ. Μαραθώνος,, 153 51 153 51, Παλλήνη Αττικής 210.6603400-6603522 - human anti-thymocyte rabbit immunoglobulin - ps.sol.inf (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ) - 25mg - human anti-thymocyte rabbit immunoglobulin